SCA
ZBH icon

Stuart Chaussee & Associates’s Zimmer Biomet ZBH Stock Holding History

Stuart Chaussee & Associates’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-37
Closed -$6K – 241
2021
Q1 		$6K Buy
+37
New +$5.73K ﹤0.01% 160

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Stuart Chaussee & Associates's ZBH Position: Q2 2021 in Review

Stuart Chaussee & Associates sold out of Zimmer Biomet (ZBH) in Q2 2021, closing a stake of 37 shares — an estimated $6K sold.

Stuart Chaussee & Associates first reported a position in ZBH in Q1 2021 and held it in 1 quarter. The position peaked at $6K in Q1 2021. 1,018 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.

  • Stuart Chaussee & Associates reported no remaining Zimmer Biomet position as of Q2 2021 after selling out during the quarter.
  • Stuart Chaussee & Associates sold 37 Zimmer Biomet shares in Q2 2021, an estimated $6K.
  • Stuart Chaussee & Associates first reported a position in Zimmer Biomet in Q1 2021 and held it in 1 quarter.
  • Stuart Chaussee & Associates's Zimmer Biomet position peaked at $6K in Q1 2021.
  • 1,018 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.

Based on Stuart Chaussee & Associates's 13F filing for Q2 2021, filed 6 Aug 2021.